Seeing Is Believing
Healthcare - Sector
ARWR is currently covered by 10 analysts with an average price target of $87.05. This is a potential upside of $16.32 (30%) from yesterday's end of day stock price of $66.96.
Arrowhead Pharmaceuticals's activity chart (see below) currently has 202 price targets and 200 ratings on display. The stock rating distribution of ARWR is 74.19% BUY and 25.81% HOLD.
Analysts average stock forecasts to be materialized ratio is 81.6% with an average time for these price targets to be met of 385.79 days.
Highest price target for ARWR is $126, Lowest price target is $35, average price target is $87.05.
Most recent stock forecast was given by DAVID LEBOWITZ from CITI on 08-Sep-2026. First documented stock forecast 07-Feb-2014.
Currently out of the existing stock ratings of ARWR, 23 are a BUY (74.19%), 8 are a HOLD (25.81%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Sep-2026
$108
$41.52 (62.45%)
$17
15 days ago
(08-Sep-2026)
7/8 (87.5%)
$22.89 (26.89%)
120
Buy Since 16-Sep-2020
$115
$48.52 (72.98%)
$115
23 days ago
(31-Aug-2026)
24/29 (82.76%)
$32.61 (39.58%)
539
Buy Since 13-May-2020
$100
$33.52 (50.42%)
$87
23 days ago
(31-Aug-2026)
19/20 (95%)
$17.61 (21.37%)
570
Buy Since 25-Sep-2015
$126
$59.52 (89.53%)
$110
2 months ago
(23-Jul-2026)
31/39 (79.49%)
$39.22 (45.19%)
581
Buy Since 23-Jul-2026
$120
$53.52 (80.51%)
$100
2 months ago
(23-Jul-2026)
3/6 (50%)
$33.22 (38.28%)
71
What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ARWR (Arrowhead Pharmaceuticals)?
Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?